Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Lasa Supergenerics Limited
No Price
Closing Price XNSE 29.04.2026:
8,10 INR
29.04.2026 09:55
Current Prices from Lasa Supergenerics Limited
Exchange
Ticker
Currency
Last Trade
Price
Daily Change
NSE
LASA.NS
INR
29.04.2026 09:55
8,10 INR
0,00 INR
MSE
LASA.BO
INR
29.04.2026 07:13
8,00 INR
-0,10 INR
-1,23 %
Share Float & Liquidity
Free Float60,95 %
Shares Float30,54 M
Shares Outstanding50,1 M
Company Profile for Lasa Supergenerics Limited Share
Lasa Supergenerics Limited engages in the research, manufacture, and marketing of animal and human healthcare products primarily in India. It offers API products comprising fenbendazole, toldimphos sodium, cyromazine, albendazole, riclabendazole, rafoxanide, ornidazole, ricobendazole, oxfendazole, closantel base, closantel sodium, nitroxynil, halquinol, and oxyclozanide, as well as 2,6-diiodo-4-nitrophenol; and other API products. The company also provides animal feed ingredients, including calcium iodate; and reagents for therapeutic use comprising potassium iodide. It also exports its products. Lasa Supergenerics Limited was incorporated in 2016 and is based in Ratnagiri, India.
